SCHEMBL8037397

SCHEMBL8037397

CC(C)(C)c1ccc2c(c1)CCC2CC(=O)O

nearest known ligand 0.57

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 17/20 0.57
PPARA Q07869 9/20 0.57
FFAR1 O14842 2/20 0.56
PPARG P37231 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8037012 0.89 PPARD (0.48) PPARDPPARAFFAR1PPARG
SCHEMBL8008760 0.85 PPARD (0.46) PPARDPPARAFFAR1PPARG
SCHEMBL8015012 0.81 PPARD (0.39) PPARDPPARAFFAR1PPARG
SCHEMBL14567149 0.81 PPARD (0.65) PPARDPPARAFFAR1PPARG
SCHEMBL16503293 0.81 PPARD (0.65) PPARDPPARAFFAR1PPARG
SCHEMBL16503302 0.81 PPARD (0.65) PPARDPPARAFFAR1PPARG
SCHEMBL8014420 0.79 ESR1 (0.40) PPARDPPARAPPARG
SCHEMBL2356852 0.79 FFAR1 (0.62) PPARDPPARAFFAR1
SCHEMBL3021109 0.79 FFAR1 (0.62) PPARDPPARAFFAR1
SCHEMBL3948386 0.79 FFAR1 (0.62) PPARDPPARAFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070191371-A1 HETEROCYCLIC MODULATORS OF PPAR KALYPSYS, INC. (US) 2007-08-16 US disclosed
US-20070191371-A1 HETEROCYCLIC MODULATORS OF PPAR KALYPSYS, INC. (US) 2007-08-16 US disclosed
EP-0685444-B1 Aromatic compounds and their use in perfumery FIRMENICH & CIE (CH) 2000-04-05 EP disclosed
EP-0685444-A1 Aromatic compounds and their use in perfumery FIRMENICH SA (CH) 1995-12-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191371-A1 HETEROCYCLIC MODULATORS OF PPAR PPARG, PPARD, PPARA PPARD 2/4885PPARA 3/4885FFAR1 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.